跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DAYQUIL COUGH DM + CONGESTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
DAYQUIL COUGH DM + CONGESTION
Authorized
STANDARD
DAYQUIL COUGH DM + CONGESTION
procter & gamble inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
b3bd0eff67901dc2
Company
procter & gamble inc
Type
Standard
Approval Details
Approval Id
b3bd0eff67901dc2
Drug Approval Canada Name
DAYQUIL COUGH DM + CONGESTION
Product Name
DAYQUIL COUGH DM + CONGESTION
Status
Marketed
Status Date
2021-07-19
Original Market Date
2021-07-19
Din
02503247
Drug Class
Human
Dosage Form
Syrup
Route Of Administration
Oral
Schedule
OTC
Ahfs
48:08.00
Atc Original
R05FA02 OPIUM DERIVATIVES AND EXPECTORANTS
Atc Name
r 05 fa 02
Aig Number
0300674006
Company Name
procter & gamble inc
Company Address
5160 Yonge Stree 14th Floor P.O. Box 355 Station A, Toronto, Ontario, Canada, M5W 1C5
Active Ingredients
GUAIFENESIN
400 MG / 30 ML
DEXTROMETHORPHAN HYDROBROMIDE
20 MG / 30 ML
PHENYLEPHRINE HYDROCHLORIDE
10 MG / 30 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
b3bd0eff67901dc2
Type
Standard
Back to Health Canada Approvals